The need for and characteristics of randomized, phase III trials to evaluate symptom management in patients with cancer
- PMID: 12189214
- DOI: 10.1093/jnci/94.16.1184
The need for and characteristics of randomized, phase III trials to evaluate symptom management in patients with cancer
Comment on
-
Double-blind, placebo-controlled, randomized phase III trial of darbepoetin alfa in lung cancer patients receiving chemotherapy.J Natl Cancer Inst. 2002 Aug 21;94(16):1211-20. doi: 10.1093/jnci/94.16.1211. J Natl Cancer Inst. 2002. PMID: 12189224 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
